Wall Street Analysts See a 357.36% Upside in Regenxbio (RGNX): Can the Stock Really Move This High?
Portfolio Pulse from
Wall Street analysts predict a significant upside of 357.36% for Regenxbio (RGNX) based on the mean of their price targets. Despite the historical inaccuracy of such metrics, the consensus on raising earnings estimates suggests potential growth for the stock.
January 24, 2025 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Regenxbio (RGNX) is projected to have a 357.36% upside according to analysts' price targets. While such targets have been unreliable in the past, the consensus on increased earnings estimates supports a positive outlook.
The article highlights a significant potential upside for RGNX based on analysts' price targets. Although these targets have not always been accurate, the strong agreement among analysts on raising earnings estimates provides a solid basis for expecting stock growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100